Connect with us
Information

NORTH AMERICA EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

NORTH AMERICA EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

lly

POPULAR ARTICLES

Lilly's Omvoh is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis

Lilly's Omvoh is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis

Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem

Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem

Lilly's Kisunla receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease

Lilly's Kisunla receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease

LATEST ARTICLES

U.S. FDA approves Inluriyo for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

U.S. FDA approves Inluriyo for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas

Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas

Lilly's Mounjaro , a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes

Lilly's Mounjaro , a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes

Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial

Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial

Lilly announces plans to build $5 billion manufacturing facility in Virginia

Lilly announces plans to build $5 billion manufacturing facility in Virginia

Lilly to participate in Bernstein's 2nd Annual Healthcare Forum

Lilly to participate in Bernstein's 2nd Annual Healthcare Forum

Latest News

Troy Minerals Achieves Key Milestone Toward Operational Mining License for Its Tsagaan Zalaa Silica Project, Mongolia

Canada One Acquires 4,836 ha Copper-Gold Property Adjacent to Copper Mountain Mine

Heliostar Metals to Present at the Metals & Mining Virtual Investor Conference October 9, 2025

Prince Silver Corp. to Present at the Metals & Mining Virtual Investor Conference October 9th

Sranan Gold Samples Up To 26.7 Grams Per Tonne Gold in The Poeketi Pit Area of The Tapanahony Project in Suriname

Outlook Reports

Precious Metals
- Gold
- Silver
Battery Metals
Agriculture

Base Metals
Critical Metals
- Rare Earths
Energy
- Uranium
- Oil and Gas

- Crypto
- Cleantech

- Biotech
- Cannabis

- Pharmaceuticals

Featured Stocks

International Graphite

IG6:AU

Skyharbour Resources

SYH:CA

African Discovery Group

AFDG

Walker Lane Resources

WLR:CC

Rua Gold

RUA:CC

Locksley Resources

LKY:AU

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES